HOMECONTACTSITE MAPSEARCH

Stock Information
NASDAQ:INFI
$5.01   + 0.04
Sep 2, 2010
4:00 PM ET
Quotes delayed at least 20 minutes. Data provided by eSignal.
Analyst Coverage

Analyst Firm Contact Information
Phil Nadeau, Ph.D. Cowen & Co.   Email: Phil.Nadeau@cowen.com
Phone: 646-562-1336
Eun Yang, Ph.D. Jefferies & Co.   Email: eyang@jefferies.com
Phone: 212-284-2264
Edward Tenthoff Piper Jaffray   Email: edward.a.tenthoff@pjc.com
Phone: 212-284-9403
Chris Raymond R.W. Baird   Email: craymond@rwbaird.com
Phone: 312-609-5437
Simos Simeonidis, Ph.D. Rodman & Renshaw   Email: ssimeonidis@rodm.com
Phone: 212-430-1790
Andrew Vaino, Ph.D. Roth Capital Partners   Email: avaino@roth.com
Phone: 949-720-7102

Infinity Pharmaceuticals, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Infinity's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Infinity or its management. Infinity does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Request Investor Kit
Shareholder Briefcase
Receive Email Alerts
Subscribe to News
Search
© 2001-2010 Infinity Pharmaceuticals, Inc. All rights reserved. | Terms | Forward Looking Statements | Privacy